Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other ...

The COVID pandemic ushered mRNA vaccines into the spotlight, and the technology has even greater potential. Here’s what to ...

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology ...

IBM and Moderna have achieved a groundbreaking milestone by simulating the longest mRNA pattern without the use of AI, instead leveraging the power of quantum computing. This collaboration marks a ...

EDITOR’S NOTE: The views expressed in this commentary are solely those of the writer. CNN is showcasing the work of The Conversation, a collaboration between journalists and academics to provide news ...

Political interference is driving biotech investment overseas, and U.S. patients and workers will pay the price.

Broader biotech positioning aligns with movements tracked across the nasdaq ecosystem.

Learn how pharma company Pfizer makes money through prescription drugs, vaccines, oncology treatments, and global ...

The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine. "We feel that a cure for cancer or to changing cancer patients' ...